Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Expands POC Health Lab Testing to Include Kidney Function Marker

• Avricore Health is a point of care pharmacy services developer that is providing lab-quality testing for select health conditions at pharmacies in Canada
• Avricore’s trademarked HealthTab(TM) platform networks patients, pharmaceutical professionals and other medical providers with a patient-privacy respecting solution that helps patients monitor their conditions at local community stores without the necessity of busy doctors’ offices scheduling
• In addition to the kidney-function monitoring solution announced just recently, HealthTab is currently outfitted to provide lab results for evaluating diabetes, heart disease, COVID, RSV, and other viral exposures
• Avricore’s pilot HealthTab rollout includes sites in eastern Canada’s Ontario province and western Canada’s British Columbia, where it is gathering information that will help its plans for a broader HealthTab rollout in Canada and other nations
• Avricore anticipates strong growth of the HealthTab network in Canada, and abroad, in 2023

Point of care health testing technology innovator Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has rolled out its trademarked HealthTab platform in select Ontario and British Columbia Shoppers Drug Mart network pharmacies and continues to add lab-accurate test functionality to its kiosks, most recently announcing a solution for monitoring kidney function.

Avricore signed a non-exclusive distribution agreement in Canada with multinational medical devices and health care company Abbott Laboratories to distribute Abbott’s handheld blood chemistry analyzer…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.